The U.S. Air Force will use a blood test made by Tethys Bioscience Inc. in a 600 person clinical trial studying better ways to prevent type 2 diabetes.
This trial will study 600 “pre-diabetic” Air Force retirees and dependents and will look at how well a behavior modification program helps keep them from developing the disease. Tethys’ test will be used at the start of the trial, and one group will be told their results, which show their risk, while a control group won’t get that information.
No comments:
Post a Comment